Abstract: An isolating pulley comprising a hub, a pulley journalled to the hub, a spring carrier journalled to the hub, a torsion spring engaged between the pulley and the spring carrier, a frictionmember engaged between the spring carrier and the hub, the frictionmember comprising a first multiple ribbed surface to engage the spring carrier and a second multiple ribbed surface to engage the hub, and the first multiple ribbed surface and the second multiple ribbed surface extending in a radial direction normal to an axis of rotation A-A.

Abstract: An isolating pulley comprising a hub, a pulley journalled to the hub, a spring carrier journalled to the hub, a torsion spring engaged between the pulley and the spring carrier, a frictionmember engaged between the spring carrier and the hub, the frictionmember comprising a first multiple ribbed surface to engage the spring carrier and a second multiple ribbed surface to engage the hub, and the first multiple ribbed surface and the second multiple ribbed surface extending in a radial direction normal to an axis of rotation A-A.

Abstract: The present invention relates to methods and compositions for the diagnosis and treatment of sepsis. The present invention also provides methods of providing a prognosis to a patient with sepsis. In particular, the present invention relates to compositions and methods for the detection of C5aR expression and the correlation of C5aR expression level with prognosis in sepsis.

Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.

Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.

Abstract: The present invention relates to methods and compositions for the diagnosis and treatment of sepsis. The present invention also provides methods of providing a prognosis to a patient with sepsis. In particular, the present invention relates to compositions and methods for the detection of C5aR expression and the correlation of C5aR expression level with prognosis in sepsis.

Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.

Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.

Abstract: Flexible control of access to a Basic Input/Output System memory is provided by a programmable non-volatile storage unit that stores a non-volatile signal and generates a control signal based on the non-volatile signal. A control circuit coupled to the programmable non-volatile storage unit receives the control signal from the non-volatile storage unit. The control circuit also receives a BIOS memory address signal and generates a modified BIOS memory address signal. In this way, different BIOS programs may be accessed on boot-up.

Abstract: Use of a polysaccharide selected from the group consisting of sulfated acid mucopolysaccharides and sulfated dextrans, and physiologically acceptable salts thereof for prophylaxis or treatment of inflammations, particularly an adult respiratory distress syndrome (ARDS), ischemic heart diseases, ischemic cerebral diseases, chronic articular rheumatism, atopic dermatitis, and infiltration after organ implantation.

Abstract: Using in vitro adhesion of recombinant rat L-selectin-Ig or rat neutrophils, it has been demonstrated that these materials bind to sulfatide that has been present in solid phase on a plastic surface. The binding activity appears to have structural requirements, with the sulfate group being critically present in position 3 on the pyranose ring of galactose. When used in vivo, it has been demonstrated that sulfated glycolipids such as brain sulfatide and ganglioside, have significantly protective effects in two models of lung inflammation, the first systemic activation of complement and the second occurring after intrapulmonary deposition of immune complexes. Both inflammatory reactions are complement, neutrophil and selectin-dependent. The protective effects of these compounds are linked to their ability to prevent the recruitment of neutrophils into lung tissue. On the basis of these findings, it is demonstrated by sulfatides and related compounds have significant in vivo anti-inflammatory activities.